Loading...

FDA Issues Draft Guidance on Cannabis Research

July 22, 2020 by Dan McCue
FDA Issues Draft Guidance on Cannabis Research

WASHINGTON – The Food and Drug Administration issued a draft guidance establishing rules for lawfully researching cannabis.

The guidance is limited to the development of drugs and does not cover other FDA-regulated products.

Nevertheless, the release of the document and publication of a Federal Register notice seeking comments has been eagerly awaited by cannabis advocates.

The new guidance stems from a 2019 public hearing during which industry representatives expressed concern about inaccurate or misleading marketing for products with CBD. Those products are not regulated by the FDA.

Since then officials from the FDA have told the House and Senate Appropriations committees that the agency “is actively evaluating what and how much data would be sufficient to support a conclusion that CBD can be safely allowed in dietary supplements under certain conditions.” 

“A range of stakeholders have expressed interest in development of drugs that contain cannabis and compounds found in cannabis. Recent legislative changes have also opened new opportunities for cannabis clinical research,” FDA Principal Deputy Commissioner Amy Abernethy said in a statement Tuesday. “As that body of research progresses and grows, the FDA is working to support drug development in this area.

“It is critical that the FDA continues to do what we can to support the science needed to develop new drugs from cannabis,” Abernethy continued. “The FDA believes the drug approval process represents the best way to ensure that safe and effective new medicines, including any drugs that contain cannabis or cannabis-derived compounds, are available to patients in need of appropriate medical therapy.”

Hemp and its derivatives such as CBD were legalized in the 2018 Farm Bill. Though CBD is derived from the marijauna plant, it does not give users a high like another chemical in the plant, THC, does.

Currently, cannabis with more than 0.3 percent THC is federally illegal, posing an obstacle for researchers to obtain the substance. 

The agency is asking that comments and suggestions about the draft document be submitted within 60 days of publication in the Federal Register of the notice announcing its availability. That publication is scheduled for Wednesday.

Electronic comments can be submitted here.

Written comments can be submitted to the Dockets Management Staff (HFA-305), Food and Drug Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852. 

All comments should be identified with the docket number listed in the notice of availability that is in the Federal Register.

For questions regarding this draft document, contact Amy Muhlberg at 240-402-6901 or Cassandra Taylor at 240-402-5290.

“The agency is committed to supporting the development of these new drugs through the investigational new drug, drug review and drug approval processes — and one key element of this support involves development of guidance, like this one,” Abernethy said.

In The News

Health

Voting

In The News

January 18, 2022
by Dan McCue
Jan. 6 Committee Subpoenas Giuliani, Other Trump Attorneys

WASHINGTON — The Select Committee to Investigate the Jan. 6 Attack on the United States Capitol issued subpoenas Tuesday evening... Read More

WASHINGTON — The Select Committee to Investigate the Jan. 6 Attack on the United States Capitol issued subpoenas Tuesday evening to Rudolph Giuliani, Jenna Ellis, Sidney Powell and Boris Epshteyn. In a tweet, the committee said simply, “The four individuals advanced unsupported theories about election fraud,... Read More

January 18, 2022
by Dan McCue
Langevin Sees Future in Retirement Rather Than Reelection

WASHINGTON — Rep. Jim Langevin, D-R.I., won’t be seeking reelection to Congress in the fall, bringing the curtain down on... Read More

WASHINGTON — Rep. Jim Langevin, D-R.I., won’t be seeking reelection to Congress in the fall, bringing the curtain down on an 11-term congressional career. “Nearly 40 years ago, a tragic accident left me paralyzed. My dreams of becoming a police officer were crushed, and I was... Read More

January 18, 2022
by Dan McCue
McNerney to Bid House Adieu After 2022

WASHINGTON — Rep. Jerry McNerney, D-Calif., the Northern California Democrat who jumped from energy to public service, announced Tuesday he’s... Read More

WASHINGTON — Rep. Jerry McNerney, D-Calif., the Northern California Democrat who jumped from energy to public service, announced Tuesday he’s retiring at the conclusion of his third term. McNerney joined 26 other Democrats who have announced they plan to leave Congress after the midterm elections. In... Read More

January 18, 2022
by Dan McCue
AT&T, Verizon to Delay 5G Rollout Near Airports

WASHINGTON — AT&T and Verizon on Tuesday agreed to delay their rollout of new 5G services near some unspecified airports... Read More

WASHINGTON — AT&T and Verizon on Tuesday agreed to delay their rollout of new 5G services near some unspecified airports over ongoing concerns that moving those services to a new band could cause flight disruptions. Debate has been raging for months over whether — and if... Read More

January 18, 2022
by Tom Ramstack
FBI Warns of More Threats Against Religious Groups

WASHINGTON — The FBI and Department of Homeland Security sent a letter to faith-based organizations Monday warning them they remain... Read More

WASHINGTON — The FBI and Department of Homeland Security sent a letter to faith-based organizations Monday warning them they remain potential targets of violent extremists. The letter followed an extremist’s attack this weekend on a synagogue in Colleyville, Texas. The gunman was killed by police who... Read More

January 18, 2022
by Dan McCue
‘Eye of Nation Watching’ as Voting Rights Bill Appears Headed for Defeat

WASHINGTON — With the defeat of sweeping voting rights legislation all but certain in the Senate this week, Majority Leader... Read More

WASHINGTON — With the defeat of sweeping voting rights legislation all but certain in the Senate this week, Majority Leader Chuck Schumer stressed a different goal as he opened the chamber’s session on Tuesday, forcing all senators to go on the record about where they stand... Read More

News From The Well
Exit mobile version